For thirty years, psychiatry bet everything on the biological model of mental illness. The drugs worked, sort of, for some people. What got lost was everything else — and now a generation is paying the price.
Rates of depression, anxiety, and suicide have risen for two decades. The clinical system designed to respond to them is failing — not by accident, but by design.
The United States pays two to three times what other wealthy countries pay for the same medications. This is a policy choice, not an economic law — and the politics of changing it are more complicated than either party admits.
Private equity has acquired thousands of medical practices, hospitals, and care facilities. The returns have been good. The patient outcomes are a different story.